What Is Ipamorelin?

Ipamorelin is a synthetic five-amino-acid peptide that acts as a ghrelin-receptor agonist and growth-hormone secretagogue. Experimental studies have examined its ability to stimulate growth-hormone release and its effects on gastrointestinal motility.

Human evidence is limited. Published studies include small pharmacology experiments in healthy volunteers and a randomized trial in postoperative ileus that did not demonstrate a statistically significant improvement in its primary efficacy outcome.

Ipamorelin is not an FDA-approved drug. Experimental mechanism or biomarker findings should not be interpreted as proof of anti-aging, body-composition, recovery, or performance benefits.

What Has Ipamorelin Been Studied For?

Ipamorelin has been studied as a growth-hormone secretagogue and ghrelin-receptor agonist. Research has examined growth-hormone pharmacology, gastrointestinal motility, and postoperative ileus.

The evidence base is substantially smaller than for approved endocrine therapies. Human studies used particular intravenous protocols and defined research populations, so their results cannot establish the safety or effectiveness of other routes, doses, or marketed wellness uses.

FDA has concluded that available information does not adequately support safety and effectiveness for the uses it reviewed.

Ipamorelin: Current Regulatory & Compounding Status

Ipamorelin is not an FDA-approved drug. FDA has concluded that available information does not adequately support its safety and effectiveness for the uses reviewed and has identified significant concerns relevant to compounding.

FDA has noted potential immunogenicity and peptide-related impurity risks for injectable preparations. The agency has also cited serious adverse events, including a death, in an intravenous clinical study and states that it lacks sufficient safety information for certain other injectable routes.

Freedom does not present ipamorelin as a currently available compounded therapy. Patients with suspected growth-hormone disorders should be evaluated by a licensed prescriber using appropriate diagnostic methods and FDA-approved treatment options.

Ipamorelin Status & Clinical Alternatives

  • Current Regulatory Status

    Ipamorelin is not FDA approved, and FDA has identified significant evidence and safety concerns relevant to compounding. Freedom does not present it as an available compounded therapy.

    Review Ipamorelin Status 

  • FDA-Approved Clinical Alternatives

    FDA-approved diagnostic and treatment options exist for defined growth-hormone disorders. A licensed prescriber can evaluate symptoms, laboratory findings, and appropriate alternatives.

    Talk to a Pharmacist 

Ipamorelin Frequently Asked Questions

Is ipamorelin FDA approved?

No. Ipamorelin is not an FDA-approved drug.

Does Freedom compound ipamorelin?

Freedom does not present ipamorelin as an available compounded therapy. FDA has identified safety and evidence concerns, and its advisory committee voted against adding ipamorelin-related substances to the 503A Bulks List.

Does ipamorelin require a prescription?

Products marketed for human use as ipamorelin should not be purchased as research chemicals. Patients should discuss lawful, FDA-approved diagnostic and treatment options with a licensed clinician.

How does ipamorelin work?

Ipamorelin acts as a ghrelin-receptor agonist and growth-hormone secretagogue. Experimental studies have examined growth-hormone release and gastrointestinal motility.

Is there human research on ipamorelin?

Limited human research exists, including small pharmacology studies and a postoperative-ileus trial. FDA concluded that the available information does not adequately support safety and effectiveness for the uses it reviewed.

What safety concerns has FDA identified?

FDA cites potential immunogenicity from aggregation or peptide impurities, complexities related to unnatural amino acids, limited route-specific safety information, and serious adverse events reported in an intravenous study.

Does Freedom sell research-use-only ipamorelin?

No. Freedom Compounding Pharmacy serves patients and licensed healthcare providers and does not sell research-use-only peptides.

Questions About Ipamorelin?

Freedom Compounding Pharmacy can help patients and licensed healthcare providers understand ipamorelin research, FDA's current concerns, and lawful clinical alternatives.

Talk to a PharmacistExplore the Peptide Library